A Phase I Trial of a Single Intravitreal Injection of REDD14NP to Patients With CNV Secondary to Wet AMD - Related Studies

A Phase I Trial of a Single Intravitreal Injection of REDD14NP to Patients With CNV Secondary to Wet AMD

This study is currently recruiting participants.

Study NCT00455481. Last updated on October 30, 2007. Information provided by Quark Pharmaceuticals

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Choroidal Neovascularization
		Macular Degeneration

2	More general conditions related to this trial
		Choroid Diseases
		Eye Diseases
		Metaplasia
		Neovascularization, Pathologic
		Pathologic Processes
		Retinal Degeneration
		Retinal Diseases
		Uveal Diseases

3	Interventions listed in this trial
		REDD14NP

4	Sponsors listed in this trial
		Quark Pharmaceuticals